Hormone Therapy

The Effects of Perioperative Gender-affirming Hormone Therapy on Facial Feminization Surgery Adverse Events, Facial Features Addressed, and Esthetic Satisfaction: A Multimodal Analysis.

TL;DR

There is a paucity of data to assess the safety or harm of continuing GAHT in the FFS perioperative period, and a shared provider-patient decision-making process examining the risks and benefits of GAHT perioperative continuation is warranted.

Key Findings

VTE incidence was numerically higher in patients who stopped GAHT perioperatively compared to those who continued it.

  • 602 patients stopped GAHT, of whom 3 VTEs were recorded (0.49%)
  • 925 patients continued GAHT perioperatively, with only 1 VTE recorded (0.11%)
  • Study heterogeneity was low (I2 = 0%)
  • Limited VTE sample size precluded meta-analytic conclusions
  • 11 articles were included in the systematic review and meta-analysis

GAHT duration did not significantly impact the incidence of all-cause complications or specific surgical complications in the retrospective cohort.

  • All-cause complications were not significantly associated with GAHT duration (P = 0.478)
  • Wound infection incidence was not significantly associated with GAHT duration (P = 0.283)
  • Hematoma incidence was not significantly associated with GAHT duration (P = 0.283)
  • VTE incidence was not significantly associated with GAHT duration (P = 1.0)
  • Analysis was conducted via retrospective review of the senior author's FFS cohort

Tracheal shaving and mandibuloplasty were the only FFS procedures significantly less associated with longer GAHT duration.

  • Tracheal shaving was significantly less associated with higher GAHT duration (P = 0.002)
  • Mandibuloplasty was significantly less associated with higher GAHT duration (P = 0.003)
  • These findings suggest GAHT may produce soft tissue and bony changes that reduce the need for these specific procedures
  • No other facial procedures showed a statistically significant association with GAHT duration

FFS revision rate was not significantly associated with GAHT duration.

  • The association between GAHT duration and FFS revision rate did not reach statistical significance (P = 0.06)
  • This finding was derived from the retrospective review of the senior author's FFS cohort
  • The result suggests GAHT duration does not meaningfully predict the need for surgical revision

A 'one-protocol-fits-all' approach to perioperative GAHT management is not appropriate given the diversity of patients seeking gender-affirming care.

  • The authors concluded that a shared provider-patient decision-making process is warranted
  • The analysis examined risks and benefits of perioperative GAHT continuation
  • The study identified a paucity of data to definitively assess the safety or harm of continuing GAHT perioperatively
  • Both systematic review/meta-analysis and retrospective cohort review methodologies were used to inform this conclusion

Have a question about this study?

Citation

Laspro M, Hoffman A, Chinta S, Abdalla J, Tran D, Oh C, et al.. (2025). The Effects of Perioperative Gender-affirming Hormone Therapy on Facial Feminization Surgery Adverse Events, Facial Features Addressed, and Esthetic Satisfaction: A Multimodal Analysis.. The Journal of craniofacial surgery. https://doi.org/10.1097/SCS.0000000000010840